Literature DB >> 3176996

An 11-year follow-up study of 110 depressed patients.

H E Lehmann1, F R Fenton, M Deutsch, S Feldman, F Engelsmann.   

Abstract

In 1972 the World Health Organization organized a cross-cultural five-centre study of depressive disorders. This report is concerned with data collected, after an 11-year follow-up period, in the sample of 110 depressed patients in Montreal, Canada. Eighty-five percent were traced and 59% were interviewed. Of 93 patients, 20 were dead at the follow-up date, 11 by suicide. Fifty-two percent of patients were receiving psychiatric treatment at follow-up, but there was no relation between psychiatric morbidity and treatment-seeking. Moderate or severe impairment of social functioning was present in 32%; in women, a trend linking the presence of social impairment and the time spent in episodes was observed. Of the episodes of psychiatric illness recorded after the index episode, 86% were diagnosed as depressive, 14% as unspecified affective disorder. The mean durations of the index and four subsequent episodes were 10, 11, 7, 11, and 2 months respectively. At least one recurrence after the index episode was reported by 78%, at least four recurrences by 19%. Episodes lasted at least one year in 5%, 4%, 6%, and 6% in the first, second, third and fourth episodes respectively. Sixteen percent were depressed for at least one year and 31% for at least 2 years. There was a marked trend from inpatient to outpatient treatment and from ECT to drug therapy over time. Twenty-two percent reported either moderate or severe problems with alcohol or substance abuse. There was a statistically significant association between the amount of time patients spent in depressive episodes and the number of life events they reported.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3176996     DOI: 10.1111/j.1600-0447.1988.tb06301.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  10 in total

1.  Sex differences in clinical predictors of suicidal acts after major depression: a prospective study.

Authors:  Maria A Oquendo; Mary E Bongiovi-Garcia; Hanga Galfalvy; Pablo H Goldberg; Michael F Grunebaum; Ainsley K Burke; J John Mann
Journal:  Am J Psychiatry       Date:  2007-01       Impact factor: 18.112

Review 2.  Paroxetine. A pharmacoeconomic evaluation of its use in depression.

Authors:  M I Wilde; R Whittington
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

3.  A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depression.

Authors:  M J Nuijten; M Hardens; E Souêtre
Journal:  Pharmacoeconomics       Date:  1995-08       Impact factor: 4.981

Review 4.  Sertraline. A pharmacoeconomic evaluation of its use in depression.

Authors:  R Davis; M I Wilde
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

5.  Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.

Authors:  R Davis; M I Wilde
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

6.  Epidemiology of chronic and nonchronic major depressive disorder: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Jose M Rubio; John C Markowitz; Analucía Alegría; Gabriela Pérez-Fuentes; Shang-Min Liu; Keng-Han Lin; Carlos Blanco
Journal:  Depress Anxiety       Date:  2011-08       Impact factor: 6.505

7.  The direct and interactive effects of neuroticism and life stress on the severity and longitudinal course of depressive symptoms.

Authors:  Timothy A Brown; Anthony J Rosellini
Journal:  J Abnorm Psychol       Date:  2011-03-07

Review 8.  [Social cognition in patients with mood disorders: part I: major depressive disorder : a comprehensive review of the literature].

Authors:  Christine Maria Hörtnagl; Stefan Oberheinricher; Alex Hofer
Journal:  Neuropsychiatr       Date:  2014-06-11

Review 9.  Predictive effects of previous episodes on the risk of recurrence in depressive and bipolar disorders.

Authors:  Lars Vedel Kessing; Per Kragh Andersen
Journal:  Curr Psychiatry Rep       Date:  2005-12       Impact factor: 8.081

10.  Screening of the unrecognised bipolar disorders among outpatients with recurrent depressive disorder: a cross-sectional study in psychiatric hospital in Morocco.

Authors:  Oneib Bouchra; Sabir Maria; Ouanass Abderazak
Journal:  Pan Afr Med J       Date:  2017-08-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.